- recruitingHuman Pharmacology (Phase I)- First administration to humans
A trial to learn if different doses of REGN17092 are safe in healthy adults
This study is looking at a new medicine called REGN17092 to see if different doses are safe for healthy adults. It's an early-stage trial trying to understand if the medicine could help with COVID-19. Participants will be carefully checked throughout the study.
Belgium - recruitingTherapeutic exploratory (Phase II)
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct)
This study is testing a new medicine called bemcentinib for people with moderate COVID-19. It aims to see if the medicine can help them get better faster and prevent them from becoming more unwell. Researchers will also check if the medicine is safe to use.
Greece · Luxembourg · Czechia - recruitingPHASE1
Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
This study is looking into how a specific type of COVID-19 (Omicron EG.5.1) affects healthy, vaccinated adults. Volunteers will be given a small amount of the virus in their nose to help scientists understand the infection and immune response, and to test future vaccines and treatments.
United Kingdom